Cantón et al. (2005) reported that aromatase (CYP19) activity evaluated in the H295R human adrenocortical carcinoma cell line showed inhibition of aromatase activity with 6CH3O-PBDE-47. Here, CYP19A1 is linked to adrenal cortex carcinoma.